Return to program book search
MOC Self-Assessment: Psoriasis
Tuition fee and ticket required for admission
Sunday, March 23
Mile High Ballroom 1DEF
3:30 PM - 5:30 PM
Robert T. Brodell, MD, FAAD
- Stephen E. Helms, MD, FAAD
- Neil J. Korman, MD, PhD, FAAD
- Julie P. Wyatt, MD, FAAD
Following this course, the attendee should be able to:
- Review clinical criteria in the diagnosis of psoriasis vulgaris.
- Analyze the risks and benefits prior to initiation of treatment.
- Recognize the role of biologic therapy in moderate to severe psoriasis vulgaris which has revolutionized the treatment of this condition in the past decade.
This session will cover psoriasis, a common disease that is seen in 2% the population in the United States and accounts for a significantly greater percentage of dermatologic practice. While the diagnosis of psoriasis vulgaris is usually straightforward, the myriad treatment options must be tailored to the needs of each patient considering risks, benefits, and costs. This session presents 25 case-based ABD approved questions that apply towards MOC Component 2 self-assessment requirements. Answers are recorded via an electronic Audience Response System (ARS), followed by discussion of the case. Immediate, anonymous feedback allows attendees to assess their knowledge and identify areas that require further self-directed study. In order to fully participate, it is imperative that participants arrive on time.
|Sunday, March 23|
|3:30 PM||The Diagnosis of Psoriasis / Dr. Brodell|
|4:00 PM||The Topical Treatment of Psoriasis / Dr. Wyatt|
|4:30 PM||Traditional Systemic Treatment of Psoriasis / Dr. Helms|
|5:00 PM||Biological Treatment of Psoriasis / Dr. Korman|